Page 9 - Bio Techne News Today

Rhenman & Partners Asset Management AB reduced its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 38.9% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 55,000 shares of the biotechnology company’s stock after selling 35,000 shares during the […]

Exploring the Financial Strength, Profitability, and Growth Metrics of Bio-Techne Corp (TECH)

Bio-Techne (NASDAQ:TECH – Get Free Report) and AVROBIO (NASDAQ:AVRO – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, dividends, profitability and institutional ownership. Profitability This table compares Bio-Techne and AVROBIO’s net margins, return […]

Benchmark reissued their buy rating on shares of Bio-Techne (NASDAQ:TECH – Free Report) in a report issued on Friday, Benzinga reports. The firm currently has a $120.00 price target on the biotechnology company’s stock. Other equities analysts also recently issued reports about the stock. Robert W. Baird cut their price target on shares of Bio-Techne […]

Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 26,662 shares of the biotechnology company’s stock after acquiring an additional 129 shares during the quarter. […]

Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,662 shares of the biotechnology company’s stock after purchasing an additional 129 shares during […]

/PRNewswire/ -- The cell culture market is set to grow by USD 17.74 billion from 2022 to 2027 progressing at a CAGR of 11.3% during the forecast period. The...

S&CO Inc. boosted its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 1.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,350 shares of the biotechnology company’s stock after purchasing an additional 270 shares during the quarter. S&CO Inc.’s holdings in Bio-Techne were […]

Barclays PLC cut its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 30.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 137,243 shares of the biotechnology company’s stock after selling 60,285 shares during the period. Barclays PLC’s holdings […]

Picton Mahoney Asset Management cut its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 49.3% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,830 shares of the biotechnology company’s stock after selling 1,776 shares during the quarter. Picton Mahoney Asset […]